Long-Term Single and Joint Effects of Excessive Daytime Napping on the HOMA-IR Index and Glycosylated Hemoglobin

Abstract This prospective cohort study was conducted to assess the duration of daytime napping and its effect combined with night sleep deprivation on the risk of developing high HOMA-IR (homeostasis model assessment of insulin resistance) index and disadvantageous changes in glycosylated hemoglobin (HbA1c) levels. A total of 5845 diabetes-free subjects (2736 women and 3109 men), 30 to 65 years of age, were targeted for this cohort study since 2008. Multiple adjusted Cox regression models were performed to evaluate the single and joint effects of daytime napping on the risk of an elevated HbA1c level and high HOMA-IR index. After an average of 4.5 years of follow-up, >30 minutes of daytime napping was significantly associated with an increased risk of an elevated HbA1c level (>6.5%) in men and women (all P trend < 0.05). Hazard ratios (HRs) for an HbA1c level between 5.7% and 6.4% were also significant in the entire cohort and women, but nonsignificant in men. HRs (95% confidence interval, CIs) for the high HOMA-IR index in the entire cohort, men, and women were 1.33 (1.10–1.62), 1.46 (1.08–1.98), and 1.47 (1.12–1.91), respectively. The combination of sleep deprivation with no naps or >30 minutes napping and the combination of no sleep deprivation with >30 minutes daytime napping were all associated with an HbA1c level >6.5% (HR = 2.08, 95% CI = 1.24–3.51; HR = 4.00, 95% CI = 2.03–7.90; and HR = 2.05, 95% CI = 1.29–3.27, respectively). No sleep deprivation combined with >30 minutes daytime napping correlated with a high risk of an HbA1c level between 5.7% and 6.4% and high HOMA-IR index (HR = 2.12, 95% CI = 1.48–3.02; and HR = 1.35, 95% CI = 1.10–1.65, respectively). Daytime napping >30 minutes was associated with a high risk of an elevated HbA1c level and high HOMA-IR index. No sleep deprivation combined with napping >30 minutes carries a risk of abnormal glucose metabolism. Sleep deprivation combined with brief daytime napping <30 minutes was not associated with a risk for an elevated HbA1c level and high HOMA-IR index.

[1]  F. Hu,et al.  Longer Sleep Duration and Midday Napping Are Associated with a Higher Risk of CHD Incidence in Middle-Aged and Older Chinese: the Dongfeng-Tongji Cohort Study. , 2016, Sleep.

[2]  G. Chrousos,et al.  HPA Axis and Sleep , 2016 .

[3]  Weiqing Wang,et al.  Elevated whole blood viscosity is associated with insulin resistance and non‐alcoholic fatty liver , 2015, Clinical endocrinology.

[4]  Cheol-Young Park,et al.  Changing Clinical Characteristics according to Insulin Resistance and Insulin Secretion in Newly Diagnosed Type 2 Diabetic Patients in Korea , 2015, Diabetes & metabolism journal.

[5]  M. Bruyneel.  Sleep disturbances in menopausal women: Aetiology and practical aspects. , 2015, Maturitas.

[6]  G. Dimitriadis,et al.  Insulin action in muscle and adipose tissue in type 2 diabetes: The significance of blood flow. , 2015, World journal of diabetes.

[7]  C. Hoyos,et al.  Meta-analyses of the Association of Sleep Apnea with Insulin Resistance, and the Effects of CPAP on HOMA-IR, Adiponectin, and Visceral Adipose Fat. , 2015, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[8]  Tangchun Wu,et al.  Daily sleep duration and risk of metabolic syndrome among middle-aged and older Chinese adults: cross-sectional evidence from the Dongfeng–Tongji cohort study , 2015, BMC Public Health.

[9]  A. Grob,et al.  In School-Age Children Who Were Born Very Preterm Sleep Efficiency Is Associated with Cognitive Function , 2015, Neuropsychobiology.

[10]  C. Brayne,et al.  Daytime napping, sleep duration and serum C reactive protein: a population-based cohort study , 2014, BMJ Open.

[11]  N. Kamaruddin,et al.  Insulin resistance using HOMA model in obstructive sleep apnea: a cross sectional study , 2014, Annals of Saudi medicine.

[12]  Philippe Boudreau,et al.  Impacts of shift work on sleep and circadian rhythms. , 2014, Pathologie-biologie.

[13]  Y. Bi,et al.  Association of napping and night-time sleep with impaired glucose regulation, insulin resistance and glycated haemoglobin in Chinese middle-aged adults with no diabetes: a cross-sectional study , 2014, BMJ Open.

[14]  R. Meirelles.  [Menopause and metabolic syndrome]. , 2014, Arquivos brasileiros de endocrinologia e metabologia.

[15]  Y. Manios,et al.  Identification of lifestyle patterns, including sleep deprivation, associated with insulin resistance in children: the Healthy Growth Study , 2014, European Journal of Clinical Nutrition.

[16]  A. Card.  Importance of sleep disorders in assessing the association between coffee consumption and all-cause mortality. , 2013, Mayo Clinic proceedings.

[17]  C. Vandelanotte,et al.  The association between short sleep and obesity after controlling for demographic, lifestyle, work and health related factors. , 2013, Sleep medicine.

[18]  T. Higgins.  HbA1c for screening and diagnosis of diabetes mellitus , 2013, Endocrine.

[19]  Yunxia Zhu,et al.  Serotonin Receptor 2C and Insulin Secretion , 2013, PloS one.

[20]  S. Lai,et al.  Urinary bisphenol A (BPA) concentration associates with obesity and insulin resistance. , 2012, The Journal of clinical endocrinology and metabolism.

[21]  Duncan J Macfarlane,et al.  Validity of the international physical activity questionnaire short form (IPAQ-SF): A systematic review , 2011, The international journal of behavioral nutrition and physical activity.

[22]  P. Penev,et al.  Changes in Insulin Secretion and Action in Adults With Familial Risk for Type 2 Diabetes Who Curtail Their Sleep , 2011, Diabetes Care.

[23]  T. Lam,et al.  Self-Reported Long Total Sleep Duration Is Associated With Metabolic Syndrome , 2011, Diabetes Care.

[24]  S. Redline,et al.  Short duration of sleep increases risk of colorectal adenoma , 2011, Cancer.

[25]  M. Kerkhofs,et al.  Benefits of napping and an extended duration of recovery sleep on alertness and immune cells after acute sleep restriction , 2011, Brain, Behavior, and Immunity.

[26]  K. Spiegel,et al.  Role of sleep duration in the regulation of glucose metabolism and appetite. , 2010, Best practice & research. Clinical endocrinology & metabolism.

[27]  Daniel J Buysse,et al.  Napping, nighttime sleep, and cardiovascular risk factors in mid-life adults. , 2010, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[28]  A. Esteghamati,et al.  Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007) , 2010, Nutrition & metabolism.

[29]  J. Doerr,et al.  Störungen des Tiefschlafs und psychische Erkrankungen , 2010, Der Nervenarzt.

[30]  L. Bretillon,et al.  Differential effect of maternal diet supplementation with α-Linolenic adcid or n-3 long-chain polyunsaturated fatty acids on glial cell phosphatidylethanolamine and phosphatidylserine fatty acid profile in neonate rat brains , 2010, Nutrition & metabolism.

[31]  H. S. Park,et al.  Relationship between sleep duration and the metabolic syndrome: Korean National Health and Nutrition Survey 2001 , 2008, International Journal of Obesity.

[32]  Issa Zakeri,et al.  Physical activity in nonoverweight and overweight Hispanic children and adolescents. , 2007, Medicine and science in sports and exercise.

[33]  Y. Oka,et al.  Increased hypothalamic 5-HT2A receptor gene expression and effects of pharmacologic 5-HT2A receptor inactivation in obese Ay mice. , 2006, Biochemical and biophysical research communications.

[34]  S. Leurgans,et al.  Association of daytime napping and Parkinsonian signs in Alzheimer's disease. , 2006, Sleep medicine.

[35]  R. Dhand,et al.  Good sleep, bad sleep! The role of daytime naps in healthy adults , 2006, Current opinion in pulmonary medicine.

[36]  U. Dhand,et al.  Sleep disorders in neuromuscular diseases , 2006, Current opinion in pulmonary medicine.

[37]  G. Marchesini,et al.  Insulin resistance: A metabolic pathway to chronic liver disease , 2005, Hepatology.

[38]  M. Sasamata,et al.  Antiobesity effect of YM348, a novel 5-HT2C receptor agonist, in Zucker rats , 2004, Brain Research.

[39]  K. Nakayama,et al.  Sleep-dependent learning: a nap is as good as a night , 2003, Nature Neuroscience.

[40]  L. Lack,et al.  The short-term benefits of brief and long naps following nocturnal sleep restriction. , 2001, Sleep.

[41]  B Bioulac,et al.  Morningness/eveningness and the need for sleep , 1999, Journal of sleep research.

[42]  T Hori,et al.  The effects of a 20‐min nap before post‐lunch dip , 1998, Psychiatry and clinical neurosciences.

[43]  Standards of Medical Care for Patients With Diabetes Mellitus , 1998, Diabetes Care.

[44]  G Kecklund,et al.  The effects of a short daytime nap after restricted night sleep. , 1996, Sleep.

[45]  R. Asplund.  Daytime sleepiness and napping amongst the elderly in relation to somatic health and medical treatment , 1996, Journal of internal medicine.

[46]  A. Bird,et al.  Day-time naps and melatonin in blind people , 1995, The Lancet.

[47]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[48]  M. Sasaki,et al.  Persistence of the circadian rhythm of REM sleep: a variety of experimental manipulations of the sleep-wake cycle. , 1981, Sleep.

[49]  A. Cerami,et al.  Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. , 1976, The New England journal of medicine.

[50]  Leszek Czupryniak,et al.  Nowy rok, stare problemy, ale i nowe możliwości , 2014 .

[51]  L. Lack,et al.  The effects of napping on cognitive functioning. , 2010, Progress in brain research.

[52]  D. Riemann,et al.  [Disturbances of slow-wave sleep and psychiatric disorders]. , 2010, Der Nervenarzt.

[53]  S. Sangiah,et al.  Reduction of rapid eye movement (REM) sleep by glucose alone or glucose and insulin in rats. , 1988, Life sciences.